表紙
市場調査レポート

ファーマシーオートメーション:各種技術と世界市場

Pharmacy Automation: Technologies and Global Markets

発行 BCC Research 商品コード 133577
出版日 ページ情報 英文 236 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ファーマシーオートメーション:各種技術と世界市場 Pharmacy Automation: Technologies and Global Markets
出版日: 2014年03月24日 ページ情報: 英文 236 Pages
概要

世界のファーマシーオートメーション市場は、2012年におよそ30億米ドルの規模となり、2013年には32億米ドル近くに達する見込みです。今後5年間の市場額はCAGR8.8%で拡大し、2018年に49億米ドルになると予測されています。

当レポートでは、入院患者および外来患者向け調剤自動化システムの世界市場について調査分析し、産業構造、市場影響因子、技術・製品、装置のコスト分析、競合構造、市場シェア、市場規模・成長率などをまとめ、ケーススタディ、主要企業のプロファイルなども盛り込み、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 産業概要

  • ファーマシーオートメーションの産業構造
  • ファーマシーオートメーション市場の背景、歴史、成長

第4章 市場に影響を及ぼす課題

  • バーコードと投薬の電子化
  • 医療従事者の動向

第5章 入院患者への調剤の自動化

  • 概要
  • システムの導入
  • 製品概要
  • 入院患者向け自動化のコスト:装置タイプ別
  • 市場規模・成長率
  • 競合構造・市場シェア

第6章 外来患者への調剤の自動化

  • 概要
  • 市場規模と成長

第7章 世界のファーマシーオートメーション市場概要

  • 世界市場:セグメント別
  • 世界市場:装置タイプ別
  • 世界の市場シェア:セグメント別
  • 世界の市場シェア:装置タイプ別
  • 世界市場:地域別
  • 市場参入企業:装置タイプ別

第8章 技術

  • 概要
  • 現在の技術利用
  • 特許評価

第9章 企業プロファイル

第10章 付録

  • 主要医薬品製造業者
  • その他の関連企業
  • 病院・医薬品小売業者・その他
  • 産業団体など

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IAS026D

The global pharmacy automation market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual growth rate (CAGR) of 8.8% over the five-year period, 2013 to 2018

This report provides:

  • An overview of the global market for pharmacy automation.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • A market breakdown of inpatient pharmacy automation into acute-care settings and long-term care settings.
  • A market breakdown of outpatient pharmacy automation into fast-track clinical settings, hospital retail settings, pharmacy benefit management services, and retail pharmacy chains
  • Comprehensive profiles of leading companies in the industry.

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC Research report, Pharmacy Automation: Technologies and Global Markets (IAS026D), provides a comprehensive analysis of the pharmacy automation market's current operations and equipment, current trends and detailed patent analysis. The study includes information regarding statistics for medication errors, costs associated with pharmacy activities, the pharmacist shortage and many other issues affecting the pharmacy automation market. Major pharmacy automation product segments include in-depth market and competitive analyses.

REASONS FOR DOING THE STUDY

Although pharmacy automation dates back to the 1970s with the introduction of pill-counting machines, the pharmacy automation market continues to advance and to deliver impressive technology and improve efficiency. The increasing demand for accuracy, safety, industry standards and competency in the pharmacy environment by regulatory authorities, manufacturers, healthcare professionals and consumers has forced the growth of this market.

New opportunities in various settings will continue to surface-from small, private, family-owned pharmacies to large hospital and mail-order service facilities. Many small, private pharmacies are still conducting operations through manual and semi-manual methods, particularly in regions outside of the United States. The opportunity to fully automate these pharmacies surfaces more often each year, and with a growing compliance with bar-coding standards and new tracking capabilities with radio-frequency identification (RFID) technology, this trend will continue to increase at a rapid rate. A large portion of inpatient facilities are already highly automated; however, there are advancements in technology and performance improvements every year, and these pharmacies will continue to seek out the most efficient system to upgrade. In order to remain competitive in the pharmaceutical dispensing business, organizations will be highly dependent on efficient automation systems. Therefore, upgrades are likely to be an ongoing process.

CONTRIBUTION OF THE STUDY AND FOR WHOM

The intended audience includes all the stakeholders of the pharmacy market: drug manufacturing companies, drug vendors, independent pharmacies, hospitals, retail pharmacy chains. This includes mostly manufacturers, retailers and super retailers, technology providers, and research and development (R&D) companies.

With its broad scope and in-depth analyses, this study will prove to be a valuable resource to anyone involved with or interested in the operations of pharmacy and more specifically automating pharmacy processes. This study will provide information on these areas:

  • Structure and current market size of the pharmacy automation market as outlined with forecasts through 2018.
  • Impact of chronic diseases, growing and aging populations.
  • Current product suppliers and some of their technologies.
  • An in-depth market evaluation of the U.S. pharmacy automation market.
  • A look at the pharmacy service industry and its value.
  • Markets for United States; Europe; and where available Asia Pacific, Latin America and the rest of world.
  • Technology patent trends relating to automating processes in the pharmacy environment.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

Since the study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, purchases, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making and system implementation, upgrades and new developments.

SCOPE AND FORMAT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the global pharmacy automation market. The geographical scope is global with special emphasis on the United States/Canada and developed Europe, with supplemental data covering other geographical markets and trends. The report identifies pharmacy automation markets by inpatient and outpatient pharmacy settings, and by product type. Within the global pharmacy automation market, there are two general pharmacy settings, each with other subsettings:

  • Inpatient pharmacy automation.
    • Acute-care settings.
    • Long-term-care settings.
  • Outpatient pharmacy automation.
    • Outpatient/fast-track clinical settings.
    • Hospital retail settings.
    • Pharmacy benefit management services and other mail-order settings.
    • Retail pharmacy chains.

Each segment is further extrapolated to provide detailed information of current and emerging products, current market estimates and market forecasts, and competitive analyses.

METHODOLOGY AND INFORMATION SOURCES

The information for this BCC Research report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 60 key executives, product managers and clinical specialists involved in the pharmacy automation industry. Secondary methods included published literature in the area of pharmacy technology and services, investment reports, company literature and various pharmacy-related business journals. All market data pertains the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year of the report is 2013, with historical data provided for 2011 and 2012, and forecast data provided for 2018. Historical base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2013 base year.

Although this study provides information on a variety of pharmacy automation equipment, it does not include a comprehensive list of products available. Many companies offer products to a variety of industry types, including, but not limited to, the following industries:

  • Appliance industry.
  • Aircraft industry.
  • Automotive industry.
  • Electrical and electronics industry.
  • Communications industry.
  • Food production industry.

Some systems not covered in this study include those that are primarily used in other industry types but are, however, designed to accommodate other settings, including the medical and pharmacy industries.

GLOSSARY OF PHARMACY-RELATED TERMS[1]

Access

Refers to a patient's ability to obtain medical care based on the availability of services, their acceptability to the patient, and the convenience of their location and hours of service.

Accreditation

The acknowledgement that an institution has met or exceeded standards set by an official review board. An example is the National Committee for Quality Assurance (NCQA) or the American Accreditation HealthCare Commission (URAC).

Average length of stay (ALOS)

Average number of days spent in the hospital by each patient (usually excluding newborns) during a given period.

Average wholesale price (AWP)

A figure reported by commercial publishers of drug pricing data, such as First DataBank, Red Book or Blue Book, based on information obtained from manufacturers, distributors, and other suppliers.

Brand name prescription drug

A prescription drug that has been patented and is only produced by one manufacturer.

Food and Drug Administration (FDA)

The Food and Drug Administration (FDA) is a Federal agency within the U.S. Department of Health and Human Services. The FDA is responsible for the safety, effectiveness, and truthful labeling of: (1) drugs and vaccines used in both humans and animals, (2) foods, (3) the blood supply, (4) medical devices, (5) transplanted tissues and (6) cosmetics.

Formulary

Listing of prescription drugs that are recommended by an insurance company based on the scientific evaluation of their safety, effectiveness, value and impact on health outcomes.

Generic drug

A brand-name medication whose patent has expired, allowing other manufacturers to produce and sell it. The generic version is known by its chemical name while drug manufacturers assign brand names. Generic and brand-name medications have the same active ingredients, but generics can cost from 20% to 60% less and may be a different color, shape and size. The FDA requires generic medications have the same quality, strength, purity and stability as brand-name medications.

Health Insurance Portability and Accountability Act of 1996 (HIPAA)

This federal law, enacted in 1996, is also referred to as Kassebaum-Kennedy after its chief sponsors. It addressed a number of subjects pertaining to health insurance coverage, including health care reform, medical savings accounts, COBRA revisions, and fraud and abuse. The most far reaching of the HIPAA components relate to administrative simplification and the protection of personal information.

Hospice

A program that provides for the physical and emotional needs of terminally ill patients and their families. Hospice care may be delivered in the home, in the hospital or in a freestanding hospice facility.

Inpatient

A person who has been admitted to and requires an overnight stay at a hospital or some other facility.

Institutional care

Care provided in a hospital or some other type of healthcare facility.

Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) - The Joint Commission

A national agency sponsored by the American Medical Association, the American College of Physicians, the American College of Surgeons and the American Hospital Association, which periodically inspects hospitals and other health care institutions and provides accreditation in recognition of satisfactory performance.

Length of stay

Refers to the period of time an individual is hospitalized.

Long-term care (LTC)

Usually refers to nursing home care plans, the term can also be used to include all forms of services, both institutional and non-institutional, that are required by people with chronic health conditions.

Mail-order drugs

A program that allows individuals to buy prescription drugs for chronic conditions through the mail; larger supplies are available than are typically dispensed at a local pharmacy.

Maximum allowable cost

The fixed dollar amount that a pharmacy benefit manager (PBM) is willing to pay per unit (e.g., tablet or capsule) for a generic or multi-source medication.

Multi-source drug

A product manufactured and/or distributed by more than one pharmaceutical company/manufacturer.

Outpatient services

Services provided to an individual who has not been admitted to a hospital or other facility. These services may be provided in the outpatient department of a hospital, in a doctor's office or in some other setting.

Pharmacy Benefit Manager (PBM)

A company that provides comprehensive pharmacy cost containment services to at risk and/or self-insured health plans. Services include pharmacy network management, drug utilization review, outcomes and disease management, rebate contracting, and benefit design recommendations.

Single-source drug

A prescription drug that has been patented and is only produced by one manufacturer.

Skilled nursing facility (SNF)

A facility licensed under applicable laws to provide inpatient care under the supervision of a medical staff or a medical director. It must provide 24-hour-a-day nursing service supervised by registered nurses.

LIST OF COMMON ACRONYMS

  • ADE: adverse drug events/experience
  • ADR: adverse drug reaction
  • CDC: United States Centers for Disease Control and Prevention
  • ECDC: European Centre for Disease Prevention and Control
  • EMEA: European Medicines Agency
  • FDA: Food and Drug Administration
  • GCP: Good Clinical Practice
  • GMP: good manufacturing practice(s)
  • HCW: healthcare waste
  • HCWM /MWM: healthcare / medical waste management
  • IM/im/i.m.: intramuscular injection
  • IU: International Units
  • IV: Intravenous
  • NHS: National Health Service, UK
  • PFS: pre-filled syringe
  • R&D: research and development
  • WHO: World Health Organization

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • CONTRIBUTION OF THE STUDY AND FOR WHOM
  • SCOPE AND FORMAT
  • METHODOLOGY AND INFORMATION SOURCES
  • GLOSSARY OF PHARMACY-RELATED TERMS [1]
  • LIST OF COMMON ACRONYMS
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH ONLINE SERVICES
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • MAJOR GLOBAL PHARMACY AUTOMATION MARKETS
  • SUMMARY TABLE GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018 ($ MILLIONS)
  • KEY TRENDS
  • LEADING MANUFACTURERS

CHAPTER 3 INDUSTRY OVERVIEW

  • PHARMACY AUTOMATION INDUSTRY STRUCTURE
  • BACKGROUND, HISTORY AND GROWTH OF THE PHARMACY AUTOMATION MARKET
    • EMPLOYING AUTOMATION TO IMPROVE CURRENT MEDICATION DELIVERY SYSTEMS
      • Areas for Improvement
      • Common Prescribing Mistakes
      • TABLE 1 LIST OF ABBREVIATIONS USED IN MEDICAL PRESCRIPTIONS AND POSSIBLE CONFUSION MEANINGS
    • REGULATORY AUTHORITIES
      • Joint Commission of Accredited Healthcare Organizations (JCAHO or Joint Commission)
      • Food and Drug Administration (FDA)
      • European Medicines Agency (EMA)
      • European Federation of Pharmaceutical Industries and Associations (EFPIA)
      • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2
      • Medicines and Healthcare Products Regulatory Agency (MHRA)
      • Royal Pharmaceutical Society (RPS)
      • National Patient Safety Agency (NPSA) 2
      • Japanese Ministry of Health, Labor and Welfare (MHLW)
      • Central Drugs Standard Control Organization (CDSCO)
      • Therapeutic Goods Administration (TGA) 2
      • China Food and Drug Administration (CFDA)
      • Federal Trade Commission
      • Drug Enforcement Administration
      • National Association of Boards of Pharmacy (NABP)
      • ANVISA - Brazilian Health Surveillance Agency

CHAPTER 4 ISSUES AFFECTING THE MARKET

  • BAR CODING AND ELECTRONIC MEDICATION ADMINISTRATION
    • MEANINGFUL USE: AN OVERVIEW
    • TABLE 2 ELECTRONIC HEALTHCARE "MEANINGFUL USE" STAGES ESTABLISHED BY CMS
    • TABLE 3 "MEANINGFUL USE" TIMELINE ESTABLISHED BY CMS
    • STANDARDIZATION OF BAR CODING
    • TRENDS IN RADIOFREQUENCY IDENTIFICATION DEVICES (RFID)
    • E-Pedigree Systems and RFID
  • HEALTHCARE PERSONNEL TRENDS
    • PHARMACY PERSONNEL
    • PHARMACISTS
      • Does Pharmacist Medication Therapy Management Result in Better Outcomes?
      • Pharmacist Occupational Outlook
      • Increasing Number of Pharmacists in Selected Regions
    • PHARMACY TECHNICIANS
      • Pharmacy Technician Occupational Outlook
    • DIRECT CARE PROVIDERS
      • Nursing Occupational Outlook
    • CONSUMER ISSUES
      • Safety 4
      • Accuracy and Accountability
    • SAFETY ISSUES
      • FDA Reform Bill
      • Institute for Safe Medication Practices (ISMP)
      • Medication Administration Errors
      • TABLE 4 AVERAGE ANNUAL ADVERSE DRUG REACTIONS AND MEDICATION ADMINISTRATION ERRORS
      • TABLE 5 WIDELY REPORTED TYPES OF MEDICATION ERRORS
      • Organizational Structure and Its Effect on Errors
      • PATIENT PROTECTION AND AFFORDABLE CARE ACT-NEW REQUIREMENTS FOR LONG-TERM-CARE FACILITIES
      • IMPACT OF TELEPHARMACY
      • COMPLIANCE ISSUES
      • NARCOTICS MANAGEMENT AND TRACKING
      • FIGURE 1 UNINTENDED OPIOID ANALGESIC OVERDOSE DEATHS, 1999 VS 2010
      • TABLE 6 BENEFITS OF PRESCRIPTION MONITORING PROGRAMS FOR MEDICAL BOARDS
      • TABLE 7 STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS
      • FIGURE 2 TOTAL NUMBER OF STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS BY YEAR OF ENACTMENT
    • RETAIL PHARMACY ISSUES
    • IMPLEMENTATION ISSUES
    • BARRIERS TO IMPLEMENTATION
    • COST-EFFECTIVENESS IN PHARMACY AUTOMATION
    • MCKESSON CORP. AND AUTOMATION IN PRACTICE
    • EYECON SYSTEM AND LAKEVIEW PHARMACY
    • PARATA SYSTEMS AND TARA PHARMACY CASE STUDY
    • RISING HEALTHCARE COSTS
    • TABLE 8 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: 1980-2010 (%)
    • FIGURE 3 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: 1980 TO 2010 (%)
    • TABLE 9 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012 (%)
    • FIGURE 4 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012 (%)
    • PHARMACEUTICAL EXPENDITURES
    • TABLE 10 PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005-2011 (%)
    • FIGURE 5 PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005-2011 (%)
    • TABLE 11 PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005-2011 ($)
    • FIGURE 6 PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005 THROUGH 2011 ($)
    • DEMOGRAPHICS AND AGING POPULATIONS
      • Global Demographics
      • TABLE 12 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
      • FIGURE 7 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
      • TABLE 13 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 (MILLIONS)
      • FIGURE 8 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND PROJECTED 2015 (MILLIONS)
      • Global Life Expectancy
      • TABLE 14 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
      • FIGURE 9 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
      • U.S. Demographics
      • TABLE 15 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050 (THOUSANDS)
      • FIGURE 10 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050 (THOUSANDS)
      • Gender, Age and Life Expectancy
      • TABLE 16 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990-2020 (YEARS)
      • FIGURE 11 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990-2020 (YEARS)
      • TABLE 17 GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010 (YEARS)
      • FIGURE 12 GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010 (YEARS)
    • HEALTHCARE SYSTEM USAGE
      • Inpatient Admissions/Nursing Homes and Assisted Living Residents
      • TABLE 18 AVERAGE YEARLY ADMISSIONS AND CURRENT RESIDENTS BY TYPE OF HEALTHCARE FACILITY IN THE U.S., 2012
      • TABLE 19 TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
      • TABLE 20 NURSING HOMES RESIDENTS BY SELECTED U.S. STATE, 2011 (NO./%)
      • TABLE 21 HOSPICE FACTS, 2011 VS. 2012
      • Trends in Hospital Length of Stay
      • TABLE 22 HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011
      • FIGURE 13 HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011 (DAYS)
    • PUBLIC HEALTHCARE SYSTEMS AROUND THE WORLD
    • TABLE 23 WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50, 2000

CHAPTER 5 INPATIENT PHARMACY AUTOMATION

  • OVERVIEW
    • ACUTE CARE SETTINGS
    • TABLE 24 ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE BY SELECTED COUNTRY, 2013 ESTIMATES
    • FIGURE 14 ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS BY SELECTED COUNTRY, 2013 ESTIMATES NUMBER
    • TABLE 25 TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
    • FOR-PROFIT AND NOT-FOR-PROFIT HOSPITALS
    • TABLE 26 U.S. COMMUNITY HOSPITAL COMPARISONS BY PROFIT TYPE, 2012
    • TABLE 27 EXAMPLES OF LEADING FOR-PROFIT U.S. HOSPITAL CHAINS, 2012
    • LONG-TERM-CARE SETTINGS
    • TABLE 28 EXAMPLES OF LEADING U.S. LONG-TERM-CARE FACILITIES, 2013
    • CORRECTIONAL FACILITIES
    • TABLE 29 U.S. STATE AND FEDERAL PRISON POPULATIONS BY SELECTED CHARACTERISTICS, 2012
    • COST ANALYSIS OF PHARMACY AUTOMATION EQUIPMENT
    • TABLE 30 COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN INPATIENT APPLICATIONS
    • IMPLEMENTING THE SYSTEMS
    • EVERGREEN HOSPITAL MEDICAL CENTER (KIRKLAND, WASH.)
    • LEESBURG REGIONAL MEDICAL CENTER (LEESBURG, FLA.)
    • MIAMI CHILDREN'S HOSPITAL (MIAMI, FLA.)
    • MOUNTAIN VIEW HOSPITAL (LAS VEGAS, N.V.)
    • MADERA MEDICAL PHARMACY (MADERA, CALIF.)
    • LUCILE PACKARD CHILDREN'S HOSPITAL (STANFORD, CALIF.)
    • UCSF MEDICAL CENTER (SAN FRANCISCO, CALIF.)
    • ST. JOSEPH HOSPITAL (SAVANNAH, GA.)
  • PRODUCT DESCRIPTIONS
    • AUTOMATED DISPENSING/STORAGE SYSTEMS
    • Narcotics and Anesthesia Management Systems
    • AUTOMATED PACKAGING SYSTEMS
    • OTHER AUTOMATED SYSTEMS
  • INPATIENT AUTOMATION COST BY EQUIPMENT TYPE
  • TABLE 31 SUMMARY OF INPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST ($)
  • MARKET SIZE AND GROWTH
    • OVERVIEW
    • FIGURE 15 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018 ($ MILLIONS)
    • MARKETS BY PRODUCT TYPE
    • TABLE 32 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 16 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS)
    • PRODUCT SALES BY END USER
    • FIGURE 17 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET SHARES BY END USER, ESTIMATED 2013 (%)
    • MARKETS BY WORLD REGION
    • TABLE 33 GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
    • FIGURE 18 GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%) 1
      • Level of Automation within Inpatient Pharmacy Settings
      • United States and Canada
      • TABLE 34 PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
      • FIGURE 19 PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
      • Developed Europe
      • TABLE 35 PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
      • FIGURE 20 PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • COMPETITIVE STRUCTURE AND MARKET SHARE
  • TABLE 36 GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER REVENUES, ESTIMATED 2013 ($ MILLIONS/%)
  • FIGURE 21 INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARES, ESTIMATED 2013 (%)

CHAPTER 6 OUTPATIENT PHARMACY AUTOMATION

  • OVERVIEW 120
  • TABLE 37 U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010 (NUMBER/$)
  • FIGURE 22 U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010 (MILLION)
  • FIGURE 23 DRUG SALES BY SELECTED COUNTRY, 2013 ESTIMATE (%)
    • PHYSICIAN OFFICE VISITS
    • TABLE 38 UNITED STATES: MEDICATION THERAPY AND NUMBER OF MEDICATIONS MENTIONED AT OFFICE VISITS, 2010*
    • TABLE 39 DOCTORS' CONSULTATIONS BY COUNTRY, 2011* (MILLIONS)
    • HOSPITAL RETAIL SETTINGS
    • PHARMACY BENEFIT MANAGEMENT SERVICES AND OTHER MAIL-ORDER SETTINGS
    • TABLE 40 EXAMPLES OF LEADING U.S. PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND OTHER MAIL-ORDER GROUPS' SALES ACTIVITY, 2012-2013
      • PBM Acquisition and Merger Activity
        • Express Scripts and Medco Health Solutions
        • SXC Health Solutions and Catalyst Health Solutions - to Form Catamaran Corp.
        • Walgreens and Drugstore.com
    • RETAIL PHARMACY CHAINS
    • TABLE 41 EXAMPLES OF LEADING U.S. RETAIL PHARMACY CHAINS' SALES ACTIVITY
    • FIGURE 24 GROWTH IN TOTAL NUMBER OF PHARMACY LOCATIONS BY PHARMACY CHAIN (NUMBER)
    • TABLE 42 U.S. RETAIL PHARMACY CHAINS: NUMBER OF LOCATIONS BY STATE, 2012-2013 (NUMBER)
    • FIGURE 25 DISTRIBUTION OF WALGREEN PHARMACIES IN THE U.S. BY STATE, FISCAL 2013
    • FIGURE 26 DISTRIBUTION OF CVS PHARMACIES IN THE U.S. BY STATE, 2012
    • FIGURE 27 DISTRIBUTION OF RITE AID PHARMACIES IN THE U.S. BY STATE, 2012-2013
    • COST ANALYSIS OF PHARMACY AUTOMATION EQUIPMENT
    • TABLE 43 EXAMPLE COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN OUTPATIENT APPLICATIONS
    • ADVANTAGES OF PHARMACY AUTOMATION FOR RETAILERS
    • IMPLEMENTING THE SYSTEM
      • Ohio Department of Mental Health (Columbus, Ohio)
      • London Drugs (Canada)
      • Med-Fast Pharmacy (Bethel Park, Pa.)
      • U.S. Navy and ScriptPro's Telepharmacy Solution
    • PRODUCT DESCRIPTIONS
      • Automated Dispensing Systems
      • Automated Packaging/Filling Systems
      • Other Automated Systems
    • COST OF OUTPATIENT AUTOMATION BY EQUIPMENT TYPE
    • TABLE 44 SUMMARY OF OUTPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST
    • MARKET SIZE AND GROWTH
    • OVERVIEW
    • FIGURE 28 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018 ($ MILLIONS)
    • MARKETS BY PRODUCT TYPE
    • TABLE 45 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 29 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS)
    • MARKETS BY WORLD REGION
    • TABLE 46 GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
    • FIGURE 30 GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%)
      • Level of Automation within Outpatient Pharmacy Settings
        • United States and Canada
        • TABLE 47 PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
        • FIGURE 31 PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
        • Developed Europe
        • TABLE 48 PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
        • FIGURE 32 PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
    • TABLE 49 GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER REVENUES, ESTIMATED 2013 (%/$ MILLIONS)
    • FIGURE 33 GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET SHARES, ESTIMATED 2013 (%)

CHAPTER 7 GLOBAL PHARMACY AUTOMATION MARKET SUMMARY

  • GLOBAL MARKET BY SEGMENT
  • TABLE 50 GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 34 GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018 ($ MILLIONS)
  • GLOBAL MARKET BY EQUIPMENT TYPE
  • TABLE 51 GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
  • FIGURE 35 GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS)
  • GLOBAL MARKET SHARES BY SEGMENT
  • TABLE 52 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, THROUGH 2018 (%)
  • FIGURE 36 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2013 (%)
  • FIGURE 37 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2018 (%)
  • GLOBAL MARKET SHARES BY EQUIPMENT TYPE
  • TABLE 53 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, THROUGH 2018 (%)
  • FIGURE 38 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2013 (%)
  • FIGURE 39 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2018 (%)
  • GLOBAL MARKET BY GEOGRAPHIC REGION
  • TABLE 54 GLOBAL PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
  • FIGURE 40 GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%)
    • GLOBAL TRENDS
      • Mexico
      • Europe
      • Australia and New Zealand
      • Canada
      • Asia
  • INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE
  • TABLE 55 INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE, 2012-2013
  • TABLE 56 PHARMACY AUTOMATION EQUIPMENT PROVIDER PRODUCT LIST

CHAPTER 8 TECHNOLOGY

  • OVERVIEW
  • CURRENT USES OF TECHNOLOGY
    • COMMUNICATION NETWORK TECHNOLOGY
    • BIOMETRIC-TYPE IDENTIFICATION TECHNOLOGY
    • INFRARED TECHNOLOGY
    • AUTOMATED PARENTERAL DISPENSERS
    • RADIO FREQUENCY IDENTIFICATION (RFID) TECHNOLOGY
    • BAR-CODE TECHNOLOGY
    • AUTOMATED PHARMACY INVENTORY MANAGEMENT (PIM) SYSTEMS
    • AUTOMATED DISPENSING CABINETS (ADCS)
    • ROBOTICS
      • Robotics in Medicine
      • Robotic Configurations
      • How Robots Mimic Human Movements
        • Robot Locomotion
          • Linear Tracks
        • Sensor Technology
      • Programming Languages
        • User Interfaces
      • Graphic Image Interfaces
      • Guidance Systems
        • Fluorescent Guidepaths
          • Solvent-Borne Guidepaths
          • Water-Borne Emulsion Guidepaths
  • PATENT EVALUATION
    • PHARMACY AUTOMATION AND PHARMACY ROBOT PATENTS
    • TABLE 57 NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013 (NUMBER)
    • FIGURE 41 NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013 (NUMBER)
    • TABLE 58 PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END, 2013
    • FIGURE 42 PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END 2013
    • PATENT HOLDER SUMMARY
      • Asteres
      • AutoMed Technologies
      • McKesson Automation
      • Medco Health Solutions
      • ScriptPro
      • Parata Systems
      • Tech Pharmacy Services

CHAPTER 9 COMPANY PROFILES

  • AESYNT INC.
  • AMERISOURCEBERGEN CORP.
  • TABLE 59 AMERISOURCEBERGEN'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 43 AMERISOURCEBERGEN'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • BAXTER INTERNATIONAL INC.
  • TABLE 60 BAXTER INTERNATIONAL'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 44 BAXTER INTERNATIONAL'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • CAPSA SOLUTIONS LLC
  • CAREFUSION CORP.
  • TABLE 61 CAREFUSION'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 45 CAREFUSION'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • CERNER CORP.
  • TABLE 62 CERNER'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 46 CERNER'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • EUCLID SPIRAL PAPER TUBE CORP.
  • HEALTH ROBOTICS, S.R.L.
  • INNOVATION ASSOCIATES
  • KIRBY LESTER LLC.
  • MCKESSON CORP.
  • TABLE 63 MCKESSON'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 47 MCKESSON'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • MEDICAL PACKAGING INC.
  • OMNICELL INC.
  • TABLE 64 OMNICELL'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 48 OMNICELL'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • PARATA SYSTEMS LLC
  • SCRIPTPRO LLC
  • SWISSLOG AG
  • TABLE 65 SWISSLOG'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 49 SWISSLOG'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • TALYST INC.
  • TCGRX

CHAPTER 10 APPENDICES

  • APPENDIX I: LEADING EQUIPMENT MANUFACTURERS
    • ADVANCED PHARMACY
    • AESYNT INC.
    • AMERISOURCEBERGEN CORP.
    • ARTROMICK INTERNATIONAL INC.
    • ASTERES INC.
    • AUTOMED TECHNOLOGIES INC.
    • BAXA CORP.
    • BAXTER INTERNATIONAL INC.
    • BRIDGE MEDICAL INC.
    • CAPSA SOLUTIONS LLC
    • CAREFUSION CORP.
    • CERNER CORP.
    • DRUG PACKAGE INC.
    • EMERSON ELECTRIC CO.
    • ERGOTRON INC.
    • EUCLID SPIRAL PAPER TUBE CORP.
    • HEALTH ROBOTICS S.R.L.
    • INNOVATION ASSOCIATES 210
    • INTERMETRO INDUSTRIES CORP.
    • JONES PACKAGING INC.
    • KIRBY LESTER LLC.
    • MANCHAC TECHNOLOGIES LLC
    • MCKESSON CORP.
    • MED-DISPENSE LLC
    • MEDICAL PACKAGING INC.
    • MEDITEC PTY LTD.
    • MEDSELECT INC.
    • M.E.D.S. INC.
    • MTS MEDICATION TECHNOLOGIES INC.
    • OMNICELL INC.
    • PARATA SYSTEMS
    • PEARSON MEDICAL TECHNOLOGIES LLC
    • PHACTS LLC
    • RUBBERMAID HEALTHCARE
    • RXSAFE LLC
    • RX SYSTEMS INC.
    • SCRIPTPRO LLC
    • SWISSLOG HOLDING AG
    • TALYST INC.
    • TCGRX
    • TOSHO CO. INC.
    • YASKAWA ELECTRIC CORP.
  • APPENDIX II: OTHER RELATED COMPANIES
    • ASSOCIATED PHARMACIES INC.
    • ASTRAZENECA PLC
    • BECKMAN COULTER INC.
    • BRISTOL-MYERS SQUIBB CO.
    • CARDINAL HEALTH INC.
    • DIEBOLD INC.
    • FAULDING PHARMACEUTICAL CO.
    • FOREST LABORATORIES INC.
    • FULCRUM INC.
    • GE HEALTHCARE
    • GLAXOSMITHKLINE PLC
    • HONEYWELL INTERNATIONAL INC.
    • IBM CORP.
    • IMPINJ INC.
    • INFOLOGIX INC.
    • INTERMEC
    • KIRO ROBOTICS S.L.
    • KVM TECHNOLOGIES
    • LUCIANO PACKAGING TECHNOLOGIES INC.
    • MEDSELECT INC.
    • MICROSOFT CORP.
    • MULTUM INFORMATION SERVICES
    • NOVARTIS INTERNATIONAL AG
    • NOVOPHARM LTD.
    • PAR EXCELLENCE SYSTEMS INC.
    • PERRIGO CO.
    • PFIZER INC.
    • PHARMITAS INC.
    • STINGER MEDICAL
    • SURGICHEM LTD
    • SYSTECH CORP.
    • TAGSYS
    • TELEPHARMACY SOLUTIONS INC
    • WAVEMARK INC.
  • APPENDIX III: HOSPITALS, RETAIL PHARMACIES, AND OTHERS
    • CATAMARAN CORP.
    • COMMUNITY HEALTH SYSTEMS INC.
    • COSTCO WHOLESALE CORP.
    • CVS CAREMARK
    • EVERGREEN HOSPITAL MEDICAL CENTER
    • EXPRESS SCRIPTS HOLDING COMPANY
    • FLAGLER HOSPITAL
    • GOLDEN LIVING
    • HCA MANAGEMENT SERVICES INC.
    • HCR MANOR CARE INC.
    • HEALTH MANAGEMENT ASSOCIATES INC.
    • IASIS HEALTHCARE CORP.
    • JACKSON HOSPITAL
    • KINDRED HEALTHCARE INC.
    • KROGER COMPANY, THE
    • LEESBURG REGIONAL MEDICAL CENTER
    • LIFEBRIDGE HEALTH-SINAI HOSPITAL OF BALTIMORE
    • LIFEPOINT HOSPITALS INC.
    • LONDON DRUGS LTD.
    • LUCILE PACKARD CHILDREN'S HOSPITAL
    • MEDCO HEALTH SOLUTIONS INC.
    • MEDIMPACT HEALTHCARE SYSTEMS INC.
    • MIAMI CHILDREN'S HOSPITAL
    • MOUNTAIN VIEW HOSPITAL
    • RITE AID CORP.
    • SAVASENIORCARE LLC
    • TENET HEALTHCARE CORP.
    • UNITED SUPERMARKETS LLC
    • UNIVERSAL HEALTH SERVICES INC.
    • UNIVERSITY OF MARYLAND MEDICAL CENTER
    • WALGREEN CO.
    • WAL-MART STORES INC.
  • APPENDIX IV: ASSOCIATIONS AND ORGANIZATIONS
    • AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
    • AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
    • AMERICAN HOSPITAL ASSOCIATION
    • AMERICAN PHARMACISTS ASSOCIATION
    • ANVISA-BRAZILIAN HEALTH SURVEILLANCE AGENCY
    • AUSTRALIAN DEPARTMENT OF HEALTH AND AGING
    • AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE
    • CANADIAN INSTITUTE FOR HEALTH INFORMATION
    • CENTERS FOR DISEASE CONTROL AND PREVENTION
    • CENTERS FOR MEDICARE AND MEDICAID SERVICES
    • CENTRAL DRUGS STANDARD CONTROL ORGANIZATION
    • CHINA FOOD AND DRUG ADMINISTRATION
    • CREIGHTON UNIVERSITY
    • DRUG ENFORCEMENT ADMINISTRATION
    • EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL (ECDC)
    • EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS
    • EUROPEAN MEDICINES AGENCY
    • EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION (EMCDDA)
    • EUROPEAN PATENT OFFICE
    • FEDERAL TRADE COMMISSION
    • FOOD AND DRUG ADMINISTRATION
    • HEALTH CANADA
    • INSTITUTE FOR SAFE MEDICATION PRACTICES
    • JAPANESE MINISTRY OF HEALTH, LABOR, AND WELFARE
    • THE JOINT COMMISSION JCAHO
    • MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
    • NATIONAL ASSOCIATION OF BOARDS OF PHARMACY
    • NATIONAL PATIENT SAFETY AGENCY
    • OHIO DEPARTMENT OF MENTAL HEALTH
    • OREGON STATE BOARD OF PHARMACY
    • ROYAL PHARMACEUTICAL SOCIETY
    • THERAPEUTIC GOODS ADMINISTRATION (TGA)
    • U.S. BUREAU OF LABOR STATISTICS
    • U.S. CENSUS BUREAU
    • U.S. DEPARTMENT OF DEFENSE
    • U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
    • U.S. PATENT AND TRADEMARK OFFICE 230
  • APPENDIX V: STATE CONTROLLED SUBSTANCES SCHEDULING AUTHORITIES AND OTHER CONTACT INFORMATION
    • ALABAMA
    • ALASKA
    • ARIZONA
    • ARKANSAS
    • CALIFORNIA
    • COLORADO
    • CONNECTICUT
    • DELAWARE
    • DISTRICT OF COLUMBIA
    • FLORIDA
    • GEORGIA
    • HAWAII
    • IDAHO
    • ILLINOIS
    • INDIANA
    • IOWA
    • KANSAS
    • KENTUCKY
    • LOUISIANA
    • MAINE
    • MARYLAND
    • MASSACHUSETTS
    • MICHIGAN
    • MINNESOTA
    • MISSISSIPPI
    • MISSOURI
    • MONTANA
    • NEBRASKA
    • NEVADA
    • NEW HAMPSHIRE
    • NEW JERSEY
    • NEW MEXICO
    • NEW YORK
    • NORTH CAROLINA
    • NORTH DAKOTA
    • OHIO
    • OKLAHOMA
    • OREGON
    • PENNSYLVANIA
    • RHODE ISLAND
    • SOUTH CAROLINA
    • SOUTH DAKOTA
    • TENNESSEE
    • TEXAS
    • UTAH
    • VERMONT
    • VIRGINIA
    • WASHINGTON
    • WEST VIRGINIA
    • WISCONSIN
    • WYOMING

LIST OF TABLES

  • SUMMARY TABLE GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 1 LIST OF ABBREVIATIONS USED IN MEDICAL PRESCRIPTIONS AND POSSIBLE CONFUSION MEANINGS
  • TABLE 2 ELECTRONIC HEALTHCARE "MEANINGFUL USE" STAGES ESTABLISHED BY CMS
  • TABLE 3 "MEANINGFUL USE" TIMELINE ESTABLISHED BY CMS
  • TABLE 4 AVERAGE ANNUAL ADVERSE DRUG REACTIONS AND MEDICATION ADMINISTRATION ERRORS
  • TABLE 5 WIDELY REPORTED TYPES OF MEDICATION ERRORS
  • TABLE 6 BENEFITS OF PRESCRIPTION MONITORING PROGRAMS FOR MEDICAL BOARDS
  • TABLE 7 STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS
  • TABLE 8 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: 1980-2010 (%)
  • TABLE 9 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012 (%)
  • TABLE 10 PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005-2011 (%)
  • TABLE 11 PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005-2011 ($)
  • TABLE 12 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
  • TABLE 13 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 (MILLIONS)
  • TABLE 14 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
  • TABLE 15 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050 (THOUSANDS)
  • TABLE 16 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990-2020 (YEARS)
  • TABLE 17 GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010 (YEARS)
  • TABLE 18 AVERAGE YEARLY ADMISSIONS AND CURRENT RESIDENTS BY TYPE OF HEALTHCARE FACILITY IN THE U.S., 2012
  • TABLE 19 TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
  • TABLE 20 NURSING HOMES RESIDENTS BY SELECTED U.S. STATE, 2011 (NO./%)
  • TABLE 21 HOSPICE FACTS, 2011 VS. 2012
  • TABLE 22 HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011
  • TABLE 23 WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50, 2000
  • TABLE 24 ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE BY SELECTED COUNTRY, 2013 ESTIMATES
  • TABLE 25 TOTAL NUMBER OF REGISTERED U.S. HOSPITALS BY TYPE, 2012
  • TABLE 26 U.S. COMMUNITY HOSPITAL COMPARISONS BY PROFIT TYPE, 2012
  • TABLE 27 EXAMPLES OF LEADING FOR-PROFIT U.S. HOSPITAL CHAINS, 2012
  • TABLE 28 EXAMPLES OF LEADING U.S. LONG-TERM-CARE FACILITIES, 2013
  • TABLE 29 U.S. STATE AND FEDERAL PRISON POPULATIONS BY SELECTED CHARACTERISTICS, 2012
  • TABLE 30 COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN INPATIENT APPLICATIONS
  • TABLE 31 SUMMARY OF INPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST ($)
  • TABLE 32 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 33 GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
  • TABLE 34 PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • TABLE 35 PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • TABLE 36 GLOBAL INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER REVENUES, ESTIMATED 2013 ($ MILLIONS/%)
  • TABLE 37 U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010 (NUMBER/$)
  • TABLE 38 UNITED STATES: MEDICATION THERAPY AND NUMBER OF MEDICATIONS MENTIONED AT OFFICE VISITS, 2010*
  • TABLE 39 DOCTORS' CONSULTATIONS BY COUNTRY, 2011* (MILLIONS)
  • TABLE 40 EXAMPLES OF LEADING U.S. PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND OTHER MAIL-ORDER GROUPS' SALES ACTIVITY, 2012-2013
  • TABLE 41 EXAMPLES OF LEADING U.S. RETAIL PHARMACY CHAINS' SALES ACTIVITY
  • TABLE 42 U.S. RETAIL PHARMACY CHAINS: NUMBER OF LOCATIONS BY STATE, 2012-2013 (NUMBER)
  • TABLE 43 EXAMPLE COST ANALYSES OF PHARMACY AUTOMATION EQUIPMENT USED IN OUTPATIENT APPLICATIONS
  • TABLE 44 SUMMARY OF OUTPATIENT PHARMACY AUTOMATION EQUIPMENT BY MANUFACTURER, EQUIPMENT TYPE AND COST
  • TABLE 45 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 46 GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
  • TABLE 47 PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • TABLE 48 PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • TABLE 49 GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER REVENUES, ESTIMATED 2013 (%/$ MILLIONS)
  • TABLE 50 GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 51 GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 52 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, THROUGH 2018 (%)
  • TABLE 53 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, THROUGH 2018 (%)
  • TABLE 54 GLOBAL PHARMACY AUTOMATION SYSTEMS REVENUES BY REGION, 2013 (%/$ MILLIONS)
  • TABLE 55 INDUSTRY PARTICIPANTS BY EQUIPMENT TYPE, 2012-2013
  • TABLE 56 PHARMACY AUTOMATION EQUIPMENT PROVIDER PRODUCT LIST
  • TABLE 57 NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013 (NUMBER)
  • TABLE 58 PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END, 2013
  • TABLE 59 AMERISOURCEBERGEN'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 60 BAXTER INTERNATIONAL'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 61 CAREFUSION'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 62 CERNER'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 63 MCKESSON'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 64 OMNICELL'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)
  • TABLE 65 SWISSLOG'S FINANCIAL SUMMARY, 2009-2013 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018 ($ MILLIONS)
  • FIGURE 1 UNINTENDED OPIOID ANALGESIC OVERDOSE DEATHS, 1999 VS 2010
  • FIGURE 2 TOTAL NUMBER OF STATES WITH ELECTRONIC PRESCRIPTION MONITORING PROGRAMS BY YEAR OF ENACTMENT
  • FIGURE 3 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: 1980 TO 2010 (%)
  • FIGURE 4 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: TOP 20 SPENDERS, 2012 (%)
  • FIGURE 5 PHARMACEUTICAL EXPENDITURES AS A PERCENTAGE OF HEALTH EXPENDITURES BY COUNTRY: 2005-2011 (%)
  • FIGURE 6 PHARMACEUTICAL EXPENDITURES PER CAPITA BY COUNTRY: 2005 THROUGH 2011 ($)
  • FIGURE 7 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
  • FIGURE 8 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND PROJECTED 2015 (MILLIONS)
  • FIGURE 9 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
  • FIGURE 10 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050 (THOUSANDS)
  • FIGURE 11 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY GENDER, 1990-2020 (YEARS)
  • FIGURE 12 GLOBAL LIFE EXPECTANCY BY GENDER AND AGE IN SELECTED COUNTRIES, 2010 (YEARS)
  • FIGURE 13 HOSPITAL USAGE STATISTICS, 2003 COMPARED TO 2011 (DAYS)
  • FIGURE 14 ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS BY SELECTED COUNTRY, 2013 ESTIMATES NUMBER
  • FIGURE 15 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018 ($ MILLIONS)
  • FIGURE 16 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS)
  • FIGURE 17 GLOBAL INPATIENT PHARMACY AUTOMATION MARKET SHARES BY END USER, ESTIMATED 2013 (%)
  • FIGURE 18 GLOBAL INPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%)
  • FIGURE 19 PERCENTAGE OF U.S. AND CANADIAN INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • FIGURE 20 PERCENTAGE OF EUROPEAN DEVELOPED REGIONS INPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • FIGURE 21 INPATIENT PHARMACY AUTOMATION EQUIPMENT MANUFACTURER MARKET SHARES, ESTIMATED 2013 (%)
  • FIGURE 22 U.S. RETAIL PRESCRIPTION DRUG SALES BY OUTLET, 1995-2010 (MILLION)
  • FIGURE 23 DRUG SALES BY SELECTED COUNTRY, 2013 ESTIMATE (%)
  • FIGURE 24 GROWTH IN TOTAL NUMBER OF PHARMACY LOCATIONS BY PHARMACY CHAIN (NUMBER)
  • FIGURE 25 DISTRIBUTION OF WALGREEN PHARMACIES IN THE U.S. BY STATE, FISCAL 2013
  • FIGURE 26 DISTRIBUTION OF CVS PHARMACIES IN THE U.S. BY STATE, 2012
  • FIGURE 27 DISTRIBUTION OF RITE AID PHARMACIES IN THE U.S. BY STATE, 2012-2013
  • FIGURE 28 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET REVENUES, 2011-2018 ($ MILLIONS)
  • FIGURE 29 GLOBAL OUTPATIENT PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS)
  • FIGURE 30 GLOBAL OUTPATIENT PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%)
  • FIGURE 31 PERCENTAGE OF U.S. AND CANADIAN OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • FIGURE 32 PERCENTAGE OF EUROPE DEVELOPED REGIONS OUTPATIENT PHARMACIES AT ESTIMATED LEVELS OF AUTOMATION, 2013 (%)
  • FIGURE 33 GLOBAL OUTPATIENT PHARMACY AUTOMATION MANUFACTURER MARKET SHARES, ESTIMATED 2013 (%)
  • FIGURE 34 GLOBAL INPATIENT AND OUTPATIENT PHARMACY AUTOMATION MARKET BY SEGMENT, 2011-2018 ($ MILLIONS)
  • FIGURE 35 GLOBAL PHARMACY AUTOMATION MARKET BY EQUIPMENT TYPE, 2011-2018 ($ MILLIONS) 1
  • FIGURE 36 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2013 (%)
  • FIGURE 37 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY SEGMENT, 2018 (%)
  • FIGURE 38 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2013 (%)
  • FIGURE 39 GLOBAL PHARMACY AUTOMATION MARKET SHARES BY EQUIPMENT TYPE, 2018 (%)
  • FIGURE 40 GLOBAL PHARMACY AUTOMATION SYSTEMS MARKET SHARES BY REGION, 2013 (%)
  • FIGURE 41 NUMBER OF PHARMACY AUTOMATION AND ROBOT PATENTS ISSUED BY YEAR, 1995-2013 (NUMBER)
  • FIGURE 42 PHARMACY AUTOMATION AND ROBOT PATENTS BY ASSIGNEE, AS OF YEAR END 2013 183
  • FIGURE 43 AMERISOURCEBERGEN'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 44 BAXTER INTERNATIONAL'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 45 CAREFUSION'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 46 CERNER'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 47 MCKESSON'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 48 OMNICELL'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
  • FIGURE 49 SWISSLOG'S GROWTH SUMMARY, 2009-2013 ($ MILLIONS)
Back to Top